Metagenomi, Inc. Common Stock (MGX) Filings

8-K

Metagenomi Announces Preclinical Data for Lead Hemophilia A Program

3 Sep 24

8-K

Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results

14 Aug 24

8-K

Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results

14 May 24

10-Q

2024 Q1

Quarterly report

14 May 24

8-K

Nasdaq listed (MGX) Business Update Call May 1st, 2024, 5pm ET Unlocking 4 Billion Years of Microbial Evolution to Create Curative Genetic Medicines

1 May 24

8-K

Metagenomi Reports Business Updates and Full Year 2023 Financial Results

27 Mar 24

10-K

2023 FY

Annual report

27 Mar 24

8-K

Amendments to Articles of Incorporation or Bylaws

13 Feb 24

424B4

Prospectus supplement with pricing info

12 Feb 24

S-8

Registration of securities for employees

9 Feb 24

EFFECT

Notice of effectiveness

9 Feb 24

CERT

Certification of approval for exchange listing

8 Feb 24

SEC STAFF

SEC staff action: Order

8 Feb 24

CORRESP

Correspondence with SEC

7 Feb 24

CORRESP

Correspondence with SEC

6 Feb 24

CORRESP

Correspondence with SEC

6 Feb 24

UPLOAD

Letter from SEC

6 Feb 24

8-A12B

Registration of securities on exchange

5 Feb 24

CORRESP

Correspondence with SEC

5 Feb 24

CORRESP

Correspondence with SEC

18 Jan 24

CORRESP

Correspondence with SEC

16 Jan 24

S-1

IPO registration

5 Jan 24

CORRESP

Correspondence with SEC

5 Jan 24

UPLOAD

Letter from SEC

20 Dec 23

DRS/A

Draft registration statement (amended)

11 Dec 23

D

$100.00 mm in equity / Series B-1 Preferred units, sold $95.79 mm, 25 investors

10 Jan 23

D

$175.37M in equity, sold $175.37M, 29 investors

7 Feb 22

D

$10M in equity, sold $10M, 2 investors

29 Mar 21

D

$40.2M in equity, sold $37.54M, 11 investors

25 Nov 20

D

$27.27M in equity / debt, sold $26.37M, 16 investors

16 Aug 19

4

Pamela Wapnick

6 Sep 24

SC 13G

Sozo Ventures III, L.P.

10 May 24

4

Jian Irish

3 Apr 24

4

Juergen Eckhardt

3 Apr 24

4

Luis Borges

3 Apr 24

4

Matthew Wein

3 Apr 24

4

Pamela Wapnick

3 Apr 24

4

Sarah B. Noonberg

3 Apr 24

4

Sebastian Bernales

3 Apr 24

4

Simon Harnest

3 Apr 24

4

Simren Delaney

3 Apr 24

4

Willard H Dere

3 Apr 24

4

Brian C. Thomas

3 Apr 24

4

Change in insider ownership

15 Feb 24

4

AKTIENGESELLSCHAFT BAYER

15 Feb 24

3

AKTIENGESELLSCHAFT BAYER

15 Feb 24

4

Sebastian Bernales

14 Feb 24

3

Initial statement of insider ownership

8 Feb 24

3

Pamela Wapnick

8 Feb 24

3

Sarah B. Noonberg

8 Feb 24

3

Luis Borges

8 Feb 24

3

Sebastian Bernales

8 Feb 24

3

Simon Harnest

8 Feb 24

3

Simren Delaney

8 Feb 24

3

Juergen Eckhardt

8 Feb 24

3

Matthew Wein

8 Feb 24

3

Brian C. Thomas

8 Feb 24

3

Willard H Dere

8 Feb 24

3

Jian Irish

8 Feb 24